Biotech companies fail to fully embrace health economics Mark Greener Newsletter Article 17 February 2013 Pages: 3 - 4
Survey results on antibacterial use trouble US pharmacists Newsletter Article 17 February 2013 Pages: 4 - 4
Health economic message not reaching real-world practice Newsletter Article 17 February 2013 Pages: 5 - 5
Ribosomal vaccine favoured in respiratory tract infection Newsletter Article 17 February 2013 Pages: 6 - 6
US healthcare expenditure for AIDS high and likely to rise Newsletter Article 17 February 2013 Pages: 7 - 7
Use nimesulide or diclofenac for treating osteoarthritis in Greece? Newsletter Article 17 February 2013 Pages: 7 - 7
News from the Society for Medical Decision Making’s annual meeting Newsletter Article 17 February 2013 Pages: 8 - 9
What are the long-term economic benefits of measles eradication? Newsletter Article 17 February 2013 Pages: 9 - 9